Who
Alison D. Silva
President and COO
Company insider
Files Form 4 as: President and COO, Jupiter Neurosciences.
In numbers
- Trades disclosed
- 16
- Buys
- 3
- Sells
- 0
- Bought
- $2,629
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 2 Jun 2025
- Last trade
- 2 Jun 2026
- Last filed
- 4 Jun 2026
Companies traded
Activity over time
1 Jun 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 2 Jun 2026filed 4 Jun 2026 | JUNS Jupiter Neurosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,027,304 at $0.00 | filing |
| 2 Jun 2026filed 4 Jun 2026 | JUNS Jupiter Neurosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,027,304 at $0.00 | filing |
| 2 Jul 2025filed 7 Jul 2025 | JUNS Jupiter Neurosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —255,320 | filing |
| 1 Jul 2025filed 3 Jul 2025 | JUNS Jupiter NeurosciencesBiotechnology | SEC FORM 4 Bought | $258250 at $1.03 | filing |
| 1 Jul 2025filed 3 Jul 2025 | JUNS Jupiter NeurosciencesBiotechnology | SEC FORM 4 Bought | $258250 at $1.03 | filing |
| 1 Jul 2025filed 3 Jul 2025 | JUNS Jupiter NeurosciencesBiotechnology | SEC FORM 4 Bought | $258250 at $1.03 | filing |
| 30 Jun 2025filed 1 Jul 2025 | JUNS Jupiter NeurosciencesBiotechnology | SEC FORM 4 Bought | $102100 at $1.02 | filing |
| 30 Jun 2025filed 1 Jul 2025 | JUNS Jupiter NeurosciencesBiotechnology | SEC FORM 4 Bought | $255250 at $1.02 | filing |
| 30 Jun 2025filed 1 Jul 2025 | JUNS Jupiter NeurosciencesBiotechnology | SEC FORM 4 Bought | $258250 at $1.03 | filing |
| 30 Jun 2025filed 1 Jul 2025 | JUNS Jupiter NeurosciencesBiotechnology | SEC FORM 4 Bought | $260250 at $1.04 | filing |
| 30 Jun 2025filed 1 Jul 2025 | JUNS Jupiter NeurosciencesBiotechnology | SEC FORM 4 Bought | $105100 at $1.05 | filing |
| 27 Jun 2025filed 1 Jul 2025 | JUNS Jupiter NeurosciencesBiotechnology | SEC FORM 4 Bought | $250250 at $1.00 | filing |
| 27 Jun 2025filed 1 Jul 2025 | JUNS Jupiter NeurosciencesBiotechnology | SEC FORM 4 Bought | $104100 at $1.04 | filing |
| 27 Jun 2025filed 1 Jul 2025 | JUNS Jupiter NeurosciencesBiotechnology | SEC FORM 4 Bought | $260250 at $1.04 | filing |
| 27 Jun 2025filed 1 Jul 2025 | JUNS Jupiter NeurosciencesBiotechnology | SEC FORM 4 Bought | $263250 at $1.05 | filing |
| 2 Jun 2025filed 1 Jul 2025 | JUNS Jupiter NeurosciencesBiotechnology | SEC FORM 4 Code M | —110,227 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.